Rocket Lab USA, Inc.

As of August 3, 2021, Rocket Lab USA, Inc. is considered risky and overvalued due to its high Price to Book Value of 33.52 and negative operational ratios, despite impressive stock performance driven by market speculation.

As of August 3, 2021, Rocket Lab USA, Inc. is considered a risky investment due to its high price-to-book ratio of 33.52, negative EV to EBITDA of -83.52, and ROE of -47.89%, indicating financial challenges despite a recent stock performance that significantly outpaced the S&P 500.

As of May 14, 2025, Rocket Lab USA, Inc. is in a bullish trend, supported by strong indicators like bullish MACD and moving averages on multiple time frames, along with significant returns compared to the S&P 500.

Rocket Lab USA, Inc. is a small-cap company in the Aerospace & Defense industry, reporting net sales of $123 million and a net loss of $61 million as of March 2025. It has a market cap of approximately $12.19 billion, with key metrics indicating a loss-making status and no dividend yield.

As of Jun 18, Rocket Lab USA, Inc. has a market capitalization of $12.19 billion, with net sales of $466.02 million and a net loss of $206.53 million over the last four quarters. Shareholder's funds are $382.45 million, and total assets amount to $1.18 billion.